FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells - 18/08/11
Reprint requests: Yoshimichi Okayama, MD, Research Unit for Allergy Transcriptome, Research Center for Allergy and Immunology, RIKEN Yokohama Institute, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.Yokohama, Tokyo, Chiba, and Tochigi, Japan
Abstract |
Background |
Topical application of a glucocorticoid is now widely recognized as the first-line therapy for bronchial asthma. However, glucocorticoid treatment is largely ineffective in relation to overproduction of sputum and lung tissue remodeling.
Objective |
The purpose of the current study was to identify human mast cell (MC) products that are related to goblet cell hyperplasia.
Methods |
The FcεRI-mediated gene expression profile of MCs was examined by using high-density oligonucleotide probe arrays and RT-PCR. Secretion of a protein, amphiregulin, by the MCs was measured by ELISA. Upregulation of mucin genes in NCI-H292 cells by amphiregulin was evaluated by real-time RT-PCR. The expression levels of amphiregulin on histological sections obtained from 40 subjects with asthma and 6 healthy control subjects were estimated by immunohistochemical staining, and the correlation with the number of goblet cells was studied.
Results |
Amphiregulin was secreted by human MCs after aggregation of FcεRI, and its expression was not inhibited by a glucocorticoid (dexamethasone). Amphiregulin upregulated mucin gene expression in airway epithelial cells. Upregulation of amphiregulin expression was observed in MCs of patients with asthma, but not normal control subjects. Furthermore, upregulation of amphiregulin in MCs significantly correlated with the extent of goblet cell hyperplasia in the mucosa of patients with bronchial asthma.
Conclusion |
These results suggest that after exposure to antigens, human MCs may induce sputum production via release of amphiregulin. Therefore, amphiregulin may be a new target molecule for treatment of overproduction of sputum in bronchial asthma.
Le texte complet de cet article est disponible en PDF.Key words : Mast cells, amphiregulin, bronchial asthma, goblet cell hyperplasia, dexamethasone
Abbreviations used : EGF, EGFR, MC, MNC, rh, SCF
Plan
| Supported in part by grants from the RIKEN Yokohama Institute, the Grants-in-Aid for Scientific Research (C) program of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (project number 14570402, to Dr Okayama), the Hokuriku Seiyaku Co, Ltd, Japanese Allergy Foundation (Dr Okayama), the AstraZeneca Asthma Research Award 2002 (Dr Okayama), the Kyowa-Hakko Co, Ltd, Foundation (Dr Okayama), and the Pharmaceutical and Medical Devices Agency with the Ministry of Health, Labour and Welfare (Millennium Genome Project, MPJ-5, to Dr Saito). Dr Okumura and Dr Sagara contributed equally to this work. |
Vol 115 - N° 2
P. 272-279 - février 2005 Retour au numéro
Article précédent
- Niflumic acid and MSI-2216 reduce TNF-⍺–induced mucin expression in human airway mucosa
- Hans-Peter Hauber, Patrick Daigneault, Saul Frenkiel, Francois Lavigne, Hsiao-Ling Hung, Roy C. Levitt, Qutayba Hamid
- Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-γ–inducible protein 10 expression in asthmatic airway mucosa
- Motonori Fukakusa, Celine Bergeron, Meri K. Tulic, Pierre-Olivier Fiset, Oday Al Dewachi, Michel Laviolette, Qutayba Hamid, Jamila Chakir
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?